METASTATIC LUNG CANCER
Clinical trials for METASTATIC LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Tough-to-Treat cancers in brain and lungs
Disease control OngoingThis study is testing an oral medication called BDTX-1535 for adults with advanced non-small cell lung cancer or glioblastoma (a type of brain tumor) that have specific genetic changes. The goal is to find the safest and most effective dose and see if the drug can shrink tumors, …
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
High-Precision radiation blasts bone tumors in major cancer trial
Disease control OngoingThis study is testing whether adding a highly focused, high-dose radiation treatment to standard care helps people with breast, lung, or prostate cancer that has spread to only a few bones (1-5 sites). It aims to see if this combined approach can keep the cancer from getting wors…
Matched conditions: METASTATIC LUNG CANCER
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New targeted drug tested for Tough-to-Treat lung cancer
Disease control OngoingThis study is testing an experimental drug called DS-1062a for people with advanced non-small cell lung cancer that has spread and stopped responding to standard treatments. About 100 participants will receive the drug by IV every three weeks to see if it shrinks their tumors and…
Matched conditions: METASTATIC LUNG CANCER
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC